학술논문
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trial.
Document Type
Article
Author
Source
Journal of Clinical Oncology; 3/1/2023, Vol. 41 Issue 7, p1434-1443, 10p
Subject
Language
ISSN
0732183X